Week 16 of 22
NOVEMBER 10 TO 17
Fiction. No real student, family or grade appears.
Should a dying patient get an unproven drug? Compassionate access against the fact that if everyone gets it outside the trial, the trial never finishes and nobody learns whether it works.
ME
Both sides of this are trying to save lives. That is what makes it cruel.
Staging is not how bad it looks, it is a defined system: size, nodes, spread. Everyone means the same thing by stage two, which is the entire point.
Chemotherapy travels everywhere and leans on cancer cells dividing more often than most normal cells, which is why its side effects land on the other fast-dividing tissues: gut lining, marrow, hair.
Drugs aimed at something specific to the tumour rather than at division in general. Fewer side effects, but only if the tumour actually has the target, which is why you test first.
A recommendation for a specific patient, with the staging, the molecular result, and the uncertainty.